Restricted Eating Time in the Treatment of Type 2 Diabetes

Recruiting N/A Interventional Study
Type 2 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
160 (estimated)
Sponsor
Steno Diabetes Center Copenhagen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The overall aim of the present study is to investigate the effectiveness of implementing a 1-year time-restricted eating (TRE)-based intervention on glycaemic control, body weight and composition, cardiometabolic risk factors, and behaviour in individuals with overweight/obesity and type 2 diabetes (T2D).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age: ≥18 years * Overweight or obesity (BMI ≥25 kg/m2) * T2D with HbA1c\>53 mmol/mol * Habitual eating window ≥12 h/day (incl. foods/snacks and energy-containing beverages) Exclusion Criteria: * Bariatric surgery or planned bariatric surgery within study duration * Use of fa…
Contacts

Jonas S Quist, PhD

+45 26176064

jonas.salling.quist@regionh.dk

CONTACT